Real-time enrollment status for this heart failure clinical trial
Current Status
Completed
Checked: June 2, 2026 at 12:19 AM UTC
| NCT Number | NCT06017609 |
| Recruiting Status | Completed |
| Condition | Heart Failure |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Akros Pharma Inc. |
| Last Updated on CT.gov | May 22, 2026 (1 week ago) |
As of June 2, 2026: Clinical trial NCT06017609 is currently completed participants. This clinical trial study for heart failure is not currently accepting new participants at 16 locations across the United States. The study is sponsored by Akros Pharma Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06017609 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06017609 was last updated 1 week ago (May 22, 2026). HelloStudys verifies this status automatically.